nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A little CFTR can change a lot: slowing cystic fibrosis progression
|
Rowe, Steven M |
|
|
5 |
2 |
p. 86-87 |
artikel |
2 |
Are fireworks a hazard for respiratory health?
|
Burki, Talha Khan |
|
|
5 |
2 |
p. 103-104 |
artikel |
3 |
Arnold Rice Rich
|
Akkermans, Rebecca |
|
|
5 |
2 |
p. 102-103 |
artikel |
4 |
Artist uses patients' experiences to create COPD landscapes
|
Lobo, Patricia |
|
|
5 |
2 |
p. 101-102 |
artikel |
5 |
Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study
|
Konstan, Michael W |
|
|
5 |
2 |
p. 107-118 |
artikel |
6 |
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study
|
Montani, David |
|
|
5 |
2 |
p. 125-134 |
artikel |
7 |
Clinical trial research in focus: do trials prepare us to deliver precision medicine in those with severe asthma?
|
Brightling, Christopher E |
|
|
5 |
2 |
p. 92-95 |
artikel |
8 |
Corrections
|
|
|
|
5 |
2 |
p. e13 |
artikel |
9 |
Corrections
|
|
|
|
5 |
2 |
p. e13 |
artikel |
10 |
Cystic fibrosis: a call for papers for the ECFS meeting
|
Grainger, Emma |
|
|
5 |
2 |
p. 97 |
artikel |
11 |
Diesel emissions from cars much worse than trucks and buses
|
Burki, Talha Khan |
|
|
5 |
2 |
p. 98 |
artikel |
12 |
Interstitial lung abnormalities: risk and opportunity
|
Ash, Samuel Y |
|
|
5 |
2 |
p. 95-96 |
artikel |
13 |
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial
|
Marty, Francisco M |
|
|
5 |
2 |
p. 135-146 |
artikel |
14 |
Is there added value in adding EUS to EBUS?
|
Labarca, Gonzalo |
|
|
5 |
2 |
p. e8 |
artikel |
15 |
Is there added value in adding EUS to EBUS? – Authors' reply
|
Korevaar, Daniël A |
|
|
5 |
2 |
p. e9 |
artikel |
16 |
Lung volume reduction for emphysema
|
Shah, Pallav L |
|
|
5 |
2 |
p. 147-156 |
artikel |
17 |
Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study
|
Yeung, Jonathan C |
|
|
5 |
2 |
p. 119-124 |
artikel |
18 |
Pulmonary veno-occlusive disease: characterising a rare but important disease
|
Hadinnapola, Charaka |
|
|
5 |
2 |
p. 89-90 |
artikel |
19 |
Racial disparities in critical care: experience from the USA
|
Chertoff, Jason |
|
|
5 |
2 |
p. e11-e12 |
artikel |
20 |
Respiratory health in Kosovo: Europe's new nation and a legacy of coal
|
Dumiak, Michael |
|
|
5 |
2 |
p. 99-100 |
artikel |
21 |
Sleep apnoea and driving: more clarity needed
|
The Lancet Respiratory Medicine, |
|
|
5 |
2 |
p. 85 |
artikel |
22 |
Theranostics in severe influenza
|
Rello, Jordi |
|
|
5 |
2 |
p. 91-92 |
artikel |
23 |
The weird and wonderful hunt for a new antibiotic
|
Mohammadi, Dara |
|
|
5 |
2 |
p. 104-105 |
artikel |
24 |
Two recent phase 2 trials of vandetanib in RET-rearranged NSCLC
|
Lee, Se-Hoon |
|
|
5 |
2 |
p. e10 |
artikel |
25 |
US authorities discourage use of nasal influenza vaccine, citing ineffectiveness
|
Furlow, Bryant |
|
|
5 |
2 |
p. 105-106 |
artikel |
26 |
Will ex-vivo lung perfusion allow a move towards daytime lung transplantation surgery?
|
Riddell, Peter |
|
|
5 |
2 |
p. 88-89 |
artikel |